A Novel Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice from Pandemic H1N1 and Highly Pathogenic H5N1 Virus Challenges

Vaccination is an effective means to protect against influenza virus. Although inactivated and live-attenuated vaccines are currently available, each vaccine has disadvantages (e.g., immunogenicity and safety issues). To overcome these problems, we previously developed a replication-incompetent PB2-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Uraki, Ryuta, Kiso, Maki, Iwatsuki-Horimoto, Kiyoko, Fukuyama, Satoshi, Takashita, Emi, Ozawa, Makoto, Kawaoka, Yoshihiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2013
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3700221/
https://ncbi.nlm.nih.gov/pubmed/23658445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00076-13
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak